Label
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
| Class | Version | Type | Effective |
|---|---|---|---|
| MAGNESIUM CATION Pharmacologic Class Indexing | 4 | Indexing - Pharmacologic Class | 20180813 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 52533-107-38 | 2019-11-27 | C162847 | 48780-1 | 9855d018-e2c7-cd31-e053-dbdaa90ab51a | Magnesium Sulfate 20 g Added to 5% Dextrose 250 mL Bag |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 52533-107-38 | Magnesium Sulfate | 250 mL in 1 BAG | INJECTION, SOLUTION | 250 | 3 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| MAGNESIUM SULFATE | ACTIVE INGREDIENT | DE08037SAB | 3 | |
| Magnesium Cation | ACTIVE MOIETY | T6V3LHY838 | 3 | |
| Dextrose | INACTIVE INGREDIENT | IY9XDZ35W2 | 3 | |
| Water | INACTIVE INGREDIENT | 059QF0KO0R | 3 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 52533-107 | 52533-107-38 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| MAGNESIUM SULFATE | DE08037SAB | ACTIB |
| Dextrose | IY9XDZ35W2 | IACT |
| Water | 059QF0KO0R | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| Dextrose | DEXTROSE | IY9XDZ35W2 | INJECTION / INTRAVENOUS | 5 %w/v | ||
| Dextrose | DEXTROSE | IY9XDZ35W2 | INJECTION / INTRAMUSCULAR | 5 %w/v | ||
| Dextrose | DEXTROSE | IY9XDZ35W2 | PASTILLE / ORAL | 826 mg | ||
| Dextrose | DEXTROSE | IY9XDZ35W2 | TABLET / SUBLINGUAL | 115.78 mg | ||
| Dextrose | DEXTROSE | IY9XDZ35W2 | TABLET, CHEWABLE / ORAL | 1286 mg | ||
| Dextrose | DEXTROSE | IY9XDZ35W2 | TROCHE / ORAL | 903.5 mg | ||
| Dextrose | DEXTROSE | IY9XDZ35W2 | SOLUTION / INTRAVENOUS | 5.05 %w/v | ||
| Dextrose | DEXTROSE | IY9XDZ35W2 | LOZENGE / BUCCAL | NA | ||
| Dextrose | DEXTROSE | IY9XDZ35W2 | TABLET, EXTENDED RELEASE / ORAL | 103.95 mg | ||
| Dextrose | DEXTROSE | IY9XDZ35W2 | SPRAY, METERED / NASAL | 50 mg | ||
| Dextrose | DEXTROSE | IY9XDZ35W2 | CONCENTRATE / ORAL | 400 mg | ||
| Dextrose | DEXTROSE | IY9XDZ35W2 | INJECTION / INTRASPINAL | 75 mg | ||
| Dextrose | DEXTROSE | IY9XDZ35W2 | INJECTION, SOLUTION / INTRATHECAL | 1925 mg | ||
| Dextrose | DEXTROSE | IY9XDZ35W2 | TABLET, DELAYED RELEASE / ORAL | NA | ||
| Dextrose | DEXTROSE | IY9XDZ35W2 | TABLET, COATED / ORAL | 132 mg | ||
| Dextrose | DEXTROSE | IY9XDZ35W2 | SOLUTION / ORAL | 2489 mg/5ml | ||
| Dextrose | DEXTROSE | IY9XDZ35W2 | POWDER, FOR SOLUTION / ORAL | NA | ||
| Dextrose | DEXTROSE | IY9XDZ35W2 | INJECTION, SOLUTION / INTRAVENOUS | 51.7 mg | ||
| Dextrose | DEXTROSE | IY9XDZ35W2 | SYRUP / ORAL | 620 mg | ||
| Dextrose | DEXTROSE | IY9XDZ35W2 | POWDER / VAGINAL | 430 mg | ||
| Dextrose | DEXTROSE | IY9XDZ35W2 | TABLET / ORAL | 183.66 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ba5bedcd-2ba7-44f4-a92b-8fcac6eaed03 | 08dc7029-9a03-46f0-aab1-22ee622cb153 | 2012-11-21 | ba5bedcd-2ba7-44f4-a92b-8fcac6eaed03 08dc7029-9a03-46f0-aab1-22ee622cb153 |
Adverse event summaries are temporarily unavailable. Other product information remains available.